Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX: 4747)

Market Cap	3.22B
Revenue (ttm)	618.33M
Net Income (ttm)	81.83M
Shares Out	44.93M
EPS (ttm)	1.83
PE Ratio	39.19
Forward PE	n/a
Dividend	1.50 (2.09%)
Ex-Dividend Date	n/a

Volume	53,000
Open	71.90
Previous Close	70.70
Day's Range	70.50 - 72.80
52-Week Range	61.20 - 91.60
Beta	-0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About Johnson Chemical Pharmaceutical Works

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorpo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 167
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2023, Johnson Chemical Pharmaceutical Works's revenue was 606.71 million, an increase of 22.65% compared to the previous year's 494.67 million. Earnings were 79.70 million, an increase of 22.90%.